Please login to the form below

Not currently logged in
Email:
Password:

MHRA

This page shows the latest MHRA news and features for those working in and with pharma, biotech and healthcare.

UK biotech Synairgen reveals promising early results for COVID-19 drug

UK biotech Synairgen reveals promising early results for COVID-19 drug

The preliminary positive results are good news for the Southampton, UK-based biotech company, and come only four months after Synairgen announced the Medicines and Healthcare products Regulatory Agency (MHRA) and

Latest news

More from news
Approximately 29 fully matching, plus 235 partially matching documents found.

Latest Intelligence

  • Integrating electronic health records into clinical trials Integrating electronic health records into clinical trials

    MHRA has encountered EHR systems that prevent internal and external monitors from accessing the data, leading researchers to print out records. ... MHRA is also working to resolve the problems it encounters when inspecting studies that use EHRs.

  • The evolution of real-world studies The evolution of real-world studies

    The UK has high hopes for the study, which the Medicines and Healthcare products Regulatory Agency (MHRA) thinks is “the first large commercial real-world pragmatic trial of its type using ... The MHRA hopes the trial will “attract global

  • “Brexit has been a catalyst for UK clinical research... it’s turbocharged change” “Brexit has been a catalyst for UK clinical research... it’s turbocharged change”

    National Institute for Health Research (NIHR) and the UK’s medicines regulator the MHRA. ... likely). While the government, the MHRA, UK pharma and all the stakeholders have made preparations for this eventuality, all are hoping that a no-deal scenario

  • Changes to look out for in Medical Devices Regulations Changes to look out for in Medical Devices Regulations

    non-approved filler material, and that there was no evidence that the MHRA or the Department of Health significantly failed to. ... The UK Medicines and Healthcare Regulatory Agency (MHRA), gave a more nuanced view:.

  • Uncertainty, austerity and Brexit Uncertainty, austerity and Brexit

    Of course, the loss is not solely confined to the UK, which provides substantial regulatory and market access expertise to the EU through the MHRA and NICE, as well as a

More from intelligence
Approximately 2 fully matching, plus 24 partially matching documents found.

Latest appointments

More from appointments
Approximately 11 fully matching, plus 7 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
KVA Digital

KVA is an award winning full-service digital communications & brand experience agency. Our healthcare expertise blends creative ‘outside-the-box’ thinking with...

Latest intelligence

How Far Do You Want To Go?
Join OPEN Health's virtual careers event on Tuesday 10th November, 15:00–17:00 GMT and discover where a career in medical communications could take you…...
"Fishbowl" Web Meeting for Internal POA Discussions: a Customer Story
Learn how our client successfully carried out a set of three virtual plan of action (POA) discussions, including one internal “Fishbowl” web meeting....
Whats the difference between patient engagement and patient experience?
We all talk a lot about patient engagement and patient experience. And sometimes, these terms are used interchangeably across the industry. But while they’re both important, they’re not the same....

Infographics